Mesalamine Reduces Intestinal ACE2 Expression Without Modifying SARS-CoV-2 Infection or Disease Severity in Mice.
David M AlvaradoJuhee SonLarissa B ThackrayMaria Florencia Gomez CastroSarada PrasadXueyang CuiNaomi M SonnekMichael S DiamondSiyuan DingMatthew A CiorbaPublished in: Inflammatory bowel diseases (2021)